Seeing Is Believing
Healthcare - Sector
Entasis Therapeutics Holdings's activity chart (see below) currently has 20 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 24.36% with an average time for these price targets to be met of 10.62 days.
Most recent stock forecast was given by from SCOTIABANK on 06-May-2022. First documented stock forecast 22-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Sep-2020
$2
$-0.19 (-8.68%)
$5
4 years 2 months 7 days ago
(06-May-2022)
1/3 (33.33%)
$0.15 (8.11%)
17
Hold
$2
$-0.19 (-8.68%)
4 years 3 months 27 days ago
(16-Mar-2022)
1/1 (100%)
$0.11 (5.82%)
68
Buy Since 19-Oct-2021
$1.8
$-0.39 (-17.81%)
4 years 4 months 5 days ago
(08-Mar-2022)
1/2 (50%)
$0.15 (9.09%)
7
Buy Since 19-Aug-2019
$1.8
$-0.39 (-17.81%)
4 years 4 months 9 days ago
(04-Mar-2022)
1/4 (25%)
$0.05 (2.86%)
11
Buy Since 22-Oct-2018
$7
4 years 8 months 22 days ago
(21-Oct-2021)
0/2 (0%)
$3.76 (116.05%)
What is ETTX (Entasis Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on ETTX (Entasis Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on ETTX (Entasis Therapeutics Holdings)?
Which analyst is the currently most bullish on ETTX (Entasis Therapeutics Holdings)?
Which analyst is the currently most reserved on ETTX (Entasis Therapeutics Holdings)?